experimental infection
Showing 1 - 25 of >10,000
Coronavirus Trial in Oxford (SARS-CoV-2 virus)
Recruiting
- Coronavirus
- SARS-CoV-2 virus
-
Oxford, Oxon, United Kingdom
- +2 more
Jan 5, 2023
Salmonella Typhi Infection Trial in Oxford (Salmonella Typhi challenge)
Completed
- Salmonella Typhi Infection
- Salmonella Typhi challenge
-
Oxford, Oxfordshire, United KingdomCentre for Clinical Vaccinology and Tropical Medicine (CCVTM)
Feb 8, 2022
COVID-19 Trial in Chicago (Experimental: Primary Cohort, Placebo Comparator: Primary Cohort - Placebo)
Active, not recruiting
- COVID-19
- Experimental: Primary Cohort
- Placebo Comparator: Primary Cohort - Placebo
-
Chicago, IllinoisUniversity of Chicago
Aug 24, 2023
Pulmonary Disease, Chronic Obstructive Trial (GSK3923868, Placebo)
Not yet recruiting
- Pulmonary Disease, Chronic Obstructive
- GSK3923868
- Placebo
- (no location specified)
May 26, 2022
Shigella Trial in Baltimore (SF2a-TT15 Shigella Vaccine, Placebo, S. flexneri 2a strain 2457T Challenge Agent)
Recruiting
- Shigella
- SF2a-TT15 Shigella Vaccine
- +2 more
-
Baltimore, MarylandUniversity of Maryland, Baltimore, Center for Vaccine Developmen
May 5, 2022
Surgical Wound Infection, Surgical Wound, Surgical Site Infection Trial in Palma De Mallorca (REDSCAR App)
Enrolling by invitation
- Surgical Wound Infection
- +2 more
- REDSCAR App
-
Palma De Mallorca, SpainUniversity Hospital Son Espases
Jul 31, 2022
Zika Virus Trial in Baltimore (ZIKV-SJRP/2016-184 Strain, Experimental: ZIKV-Nicaragua/2016 Strain, Placebo)
Recruiting
- Zika Virus
- ZIKV-SJRP/2016-184 Strain
- +2 more
-
Baltimore, MarylandJohns Hopkins University, Bloomberg School of Public Health
Sep 26, 2022
Covid19 Trial in London
Completed
- Covid19
-
London, United KingdomhVIVO Services Ltd, QMB Bioenterprise building
Sep 7, 2021
Gonococcal Infection Trial in Chapel Hill (Azithromycin, Ceftriaxone, Ciprofloxacin)
Completed
- Gonococcal Infection
- Azithromycin
- +4 more
-
Chapel Hill, North CarolinaUniversity of North Carolina Health Care - Infectious Diseases
Nov 2, 2021
Treatment Compliance Trial in Karachi (to evaluate the safety and efficacy of Ansa for the treatment of UTi and control of Ecoli
Recruiting
- Treatment Compliance
- to evaluate the safety and efficacy of Ansa for the treatment of UTi and control of Ecoli infection
-
Karachi, Sindg, Pakistan
- +1 more
Oct 6, 2022
Infectious Disease, Yellow Fever, Japanese Encephalitis Trial (Stamaril, Imojev, Ixiaro)
Not yet recruiting
- Infectious Disease
- +3 more
- Stamaril
- +2 more
- (no location specified)
Oct 3, 2022
Gonorrhea Male Trial in Chapel Hill (Cefixime, Ceftriaxone, Ciprofloxacin)
Recruiting
- Gonorrhea Male
- Cefixime
- +6 more
-
Chapel Hill, North CarolinaClinical and Translational Research Center (CTRC) at University
May 19, 2022
Airway Remodeling and Rhinovirus in Asthmatics
Recruiting
- Asthma
- Respiratory Disease
- HRV-39
-
Calgary, Alberta, CanadaUniversity of Calgary
Mar 7, 2023
Malaria, Vivax Trial in Oxford (Plasmodium vivax infection, Collection of 250mL blood from each volunteer (N=2))
Active, not recruiting
- Malaria, Vivax
- Plasmodium vivax infection
- Collection of 250mL blood from each volunteer (N=2)
-
Oxford, Oxfordshire, United Kingdom
- +1 more
Apr 27, 2022
COVID, Sars-CoV2, Corona Virus Infection Trial in Worcester (Convalescent Plasma)
Available
- COVID
- +2 more
- Convalescent Plasma
-
Worcester, MassachusettsUMass Medical School
Mar 6, 2022
Bacterial Vaginosis, Vaginal Disease, Bacterial Infections Trial in Randwick (Experimental: Low dose LABTHERA-001 capsule,
Recruiting
- Bacterial Vaginosis
- +4 more
- Experimental: Low dose LABTHERA-001 capsule
- +5 more
-
Randwick, New South Wales, AustraliaScientia Clinical Research
Jan 30, 2023
Plasmodium Vivax Infection Trial in Bangkok (An inoculum of malaria parasitised red blood cells with whole dose blood-stage
Recruiting
- Plasmodium Vivax Infection
- An inoculum of malaria parasitised red blood cells with whole dose blood-stage inoculum
- +3 more
-
Bangkok, ThailandFaculty of Tropical Medicine
Jun 21, 2022
Pelvic Inflammatory Disease in COVID-19 Era
Recruiting
- Pelvic Inflammatory Disease
- impact of COVID-19 on Health-Seeking Behaviors
-
Ferrara, ItalySection of Obstetrics and Gynecology, Department of Morphology,
Dec 9, 2022
HIV-1-infection Trial in London (ConM SOSIP, EDC ConM SOSIP, ConS UFO)
Active, not recruiting
- HIV-1-infection
- ConM SOSIP
- +4 more
-
London, United KingdomNIHR Imperial Clinical Resarch Facility
Jul 25, 2022
Study of the Use of the Drug Ingaron in Patients With COVID-19
Completed
- COVID-19 Respiratory Infection
- Viral Pneumonia
- Interferon Gamma
-
Moscow, Russian FederationCity Clinical Hospital named after M.E. Zhadkevich Moscow City H
May 23, 2022
COVID-19: SARS-CoV-2-CZ-PREVAL-II Study
Completed
- COVID-19
- SARS-CoV-2 Infection
- Quantitative analysis of SARS-CoV-2 antibodies
- Cellular immunity
-
Prague, CzechiaInstitute of Health Information and Statistics of the Czech Repu
Nov 25, 2022
Human Microbiome, Antibiotic Resistant Infection, Nursing Homes Trial in Seville (PROA Experimental, PROA Control)
Completed
- Human Microbiome
- +2 more
- PROA Experimental
- PROA Control
-
Seville, SpainVirgen del Rocío University Hospital
Mar 15, 2022
Gonococcal Infection Trial in Chapel Hill (Cefixime, Ceftriaxone, Ciprofloxacin)
Completed
- Gonococcal Infection
- Cefixime
- +4 more
-
Chapel Hill, North CarolinaUniversity of North Carolina Health Care - Infectious Diseases
Feb 26, 2021